JPRN-UMIN000009927已完成2 期
Analysis of efficacy and immunomodulatory activity of lenalidomide alone in relapse and refractory multiple myeloma - Immunomoduratory activity for MM treated with lenalidomide
Hematology, Respiratory Medicine and Oncology,Faculty of Medicine, Saga University0 个研究点目标入组 33 人开始时间: 2013年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 81years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) previously administered lenalidomide 2) hypersensitive reaction for lenalidomide, thalidomide and dexamethazone 3) non-secretory myeloma, solitary plasmacytoma, plasmacell leukemia and POEMS syndrome 4) CTCAE more than grade 3 neutropenia, thrombocytopenia 5) HBsAg is positive 6) HCV is positive, HIV is positive 7) uncontrollable liver dysfunction, renal insufficiency, cardiac dysfunction, respiratory dysfunction, diabetus mellitus, hypertension and infection 8) double cancer 9) psychoneurotic disorder, depression state or history 10) pregnant female, possible pregnancy or durling lactation 11) pulomonary fibrosis and interstitial pneumonitis interstitial shadow on chest CT, even if no sympton 12) physicians' decision
研究者
相似试验
招募中
3 期
Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level studyCTRI/2020/06/025861Department of Ayush Uttarakhand
招募中
3 期
Evaluation of therapeutic effects of Crocina in knee osteoarthritisosteoarthritis.Primary osteoarthritis of other jointsM19.0IRCT20190419043318N1Bojnourd University of Medical Sciences60
已完成
3 期
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
已完成
Unknown
Verification on the immunomodulatory effects of continuous consumption of dairy productsHealthy adultJPRN-UMIN000053187Meiji Co., Ltd140
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16